It is reported that coronavirus needs ACE-2 expression in the oral cavity mucosa; thus, there is a potentially substantial COVID-19 infectious vulnerability risk for oral cavity [51], and microaspiration of oropharyngeal secretions are deemed responsible for severe respiratory diseases. The gene discussed is ACE2; the disease is COVID-19.